Rotavirus reassortant vaccine
US6113910A · kind A · utility
12Cited by
18References
43Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 11, 1998 |
| Grant date | Sep 5, 2000 |
| Priority date | — |
| Expiry date | May 11, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2720/12334
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel rotavirus reassortants, vaccines employing the novel reassortants and methods for their preparation and administration. One such reassortant contains the gene encoding the v.p.7 neutralization antigen of a human rotavirus. Another reassortant contains the gene encoding the v.p.4 neutralization antigen of a human rotavirus. The remaining genes are provided solely from the bovine rotavirus WC3 strain, or from both the human and bovine strains.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.